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Coronary artery disease is commonly cited as a mechanism underlying diastolic dysfunction [11] . Many of the same factors that contribute to atherosclerosis may also produce LV diastolic dysfunction by either direct mechanisms (e.g., hypertension and age-related vascular stiffening) or secondarily via coronary artery disease progression and resulting changes in myocardial compliance [11] .
There are limited and controversial published data on the relationship of CAC to LV diastolic function. Edvardsen et al. [12] reported that coronary atherosclerosis is associated with depressed regional LV systolic and diastolic wall strain measured by MRI tagging. Colletti et al. [13] found that a CAC score greater than 100 predicts an increased likelihood of clinically unsuspected LV regional wall motion abnormalities, which are C ardiovascular disease is the most frequent cause of death and disability in patients with type 2 diabetes mellitus (DM2). DM2 is responsible for diverse cardiovascular complications such as increased coronary atherosclerosis and left ventricular (LV) dysfunction. LV diastolic dysfunction is highly prevalent in DM2 [1, 2] , representing the earliest preclinical manifestation of LV dysfunction in patients with this condition [3] [4] [5] [6] .
Over the past decade, cardiac MRI has been widely accepted as the reference standard for the assessment of cardiac structure and function because of its high spatial and temporal resolution, excellent image quality, and lack of geometric assumptions [7] . Cardiac MRI offers a variety of alternative approaches for evaluating diastolic function [8, 9] .
The presence of coronary artery calcium (CAC) is indicative of coronary atheroscle-OBJECTIVE. The purpose of this study was to compare cardiac MRI-derived parameters of left ventricular (LV) diastolic function between uncomplicated type 2 diabetes mellitus (DM2) and normoglycemic control subjects and to evaluate whether these parameters of LV diastolic function are related to coronary atherosclerosis.
SUBJECTS AND METHODS.
We prospectively studied 41 subjects with DM2 and 21 normoglycemic control subjects (30 women and 32 men; mean age, 57.2 ± 7.1 [SD] years) with no evidence of overt cardiovascular disease. We used cardiac MRI to measure LV volumes, LV peak filling rate (PFR), and transmitral flow and CT to determine coronary artery calcium scores.
RESULTS. Absolute values of the peak filling rate (PFR) were significantly lower in DM2 patients than in control subjects (mean ± SD, 293.2 ± 51.7 vs 375.7 ± 102.8 mL/s, respectively; p < 0.001). Mitral peak E velocities (mean ± SD, 42.8 ± 10.7 vs 48.8 ± 10.4 cm/s; p = 0.040) and peak E velocity-to-peak A velocity ratios (0.88 ± 0.3 vs 1.1 ± 0.3; p = 0.002) were also lower in DM2 patients compared with control subjects. DM2 patients with coronary artery calcification showed a lower PFR normalized to stroke volume (SV) (mean ± SD, 4.4 ± 1.0 vs 5.3 ± 1.4, respectively; p = 0.038) and lower mitral peak E velocities (40.1 ± 11.3 vs 48.0 ± 7.3 cm/s; p = 0.024) than DM2 patients without coronary calcification. PFR normalized to SV was independently associated with the presence of coronary artery calcification (β = -1.5, p = 0.005).
CONCLUSION. DM2 decreases cardiovascular MRI-derived parameters of LV diastolic function. Patients with DM2 and coronary atherosclerosis show a more impaired LV diastolic function than patients without coronary atherosclerosis.
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associated with lower LV ejection fractions (LVEFs) and peak filling rates (PFRs), as assessed with cardiac MRI. The results of a study by Eleid et al. [14] pointed to different conclusions. Their results in asymptomatic patients with a normal LVEF and negative findings on a cardiac stress test showed that CAC does not correlate with LV diastolic function as defined by established Doppler echocardiographic criteria.
Although all of these studies included patients with DM2, none specifically studied this population. Accordingly, the purpose of this study was to compare cardiac MRI-derived parameters of diastolic function between well-controlled uncomplicated DM2 and normoglycemic control subjects and to evaluate whether these cardiac MRI-derived parameters of LV diastolic function are related to coronary atherosclerosis.
Cardiac MRI was used to measure parameters of LV diastolic function, and the presence of coronary atherosclerosis was assessed by means of CAC scoring.
We hypothesized that in asymptomatic diabetic patients diastolic function as measured by mitral flow velocities and PFR will be reduced with the presence of coronary atherosclerosis. We also hypothesized that asymptomatic diabetic patients will have reduced diastolic function compared with normoglycemic control subjects.
Subjects and Methods

Study Population
We prospectively enrolled 41 subjects (21 women and 20 men) with DM2 referred to the outpatient clinical Department of Diabetology of our institution and 21 age-and sex-matched normoglycemic control subjects (nine women and 12 men) recruited from the community.
Subjects were included if they met the following inclusion criteria: age between 45 and 75 years, no symptoms or history of overt heart disease (cardiomyopathy, coronary artery disease, or valvular heart disease), no signs or symptoms of cerebrovascular disease, no abnormal findings on routine clinical and physical examinations, and normal ECG results.
Exclusion criteria were an LVEF of less than 55%, regional LV wall motion abnormalities, and valvular heart diseases assessed by cardiovascular MRI; severe renal failure; claustrophobia; cardiovascular MR images unsuitable for quantification; type 1 diabetes mellitus; severely uncontrolled diabetes mellitus (defined as glycated hemoglobin > 12%); and uncontrolled blood pressure at rest (defined as systolic blood pressure > 180 mm Hg or diastolic blood pressure > 100 mm Hg). Subjects with contraindications to cardiovascular MRI were not enrolled.
The study was approved by our institutional ethics committee. Each subject gave written informed consent.
Coronary Artery Calcium Score, Data Acquisition, and Analysis CAC scoring was performed only in the DM2 group. For this purpose, unenhanced low-dose ECG-gated scanning using a 64-MDCT scanner (LightSpeed VCT XT, GE Healthcare) was performed with prospective triggering at 75% of the R-R interval. All examinations included the entire coronary tree and were performed with the patient breath-holding in inspiration. The scanning parameters were as follows: FOV, 25 cm; slice thickness, 2.5 mm; gantry rotation time, 0.35 second; tube current, 100-400 mA; and tube voltage, 120 kV.
The CAC score was determined by an experienced observer using dedicated software (SmartScore version 4.0, GE Healthcare). The total CAC score was calculated for each patient using the Agatston method [15] . For the final analysis, patients were categorized in one of two groups: group 1, CAC score greater than 0; or group 2, CAC score equal to 0.
Cardiac MRI Protocol
Cardiac MRI was performed using a 3-T unit (Magnetom Trio, Siemens Healthcare). Cardiac cine images were acquired using steady-state free- Fig. 1-48 precession sequences with retrospective ECG gating [16] . Participants were imaged in the supine position and performed a breath-hold at end expiration for each image acquisition to eliminate respiratory motion artifacts. After scout images were obtained, cine imaging was performed in four-chamber, three-chamber, and two-chamber long-and short-axis views with the use of the following parameters: 8-mm-thick sections with a 2-mm gap between sections; TR/TE, 59.04/1.45; number of segments, 18; flip angle, 50°; matrix, 256 × 156; pixel size, 2.1 × 1.6 mm; acquired temporal resolution, 25-40 ms; and number of reconstructed cardiac phases, 25.
A breath-held retrospectively vector ECG-gated 2D flow-sensitive phase-contrast gradient-echo sequence was used for velocity-encoded MRI flow measurements perpendicular to the orifice of the mitral valve. Velocity-encoded MRI slices were positioned in early diastole at the tip of the mitral valve leaflets. Typical imaging parameters of velocity-encoded MRI were as follows: slice thickness, 6 mm; TR/TE, 35.6/2.33; number of segments, 3; acquired temporal resolution, 24-56 ms; flip angle, 20°; 25 calculated phases; and pixel spacing, 4.5 × 3.1 mm. The encoding velocity was set to 130 cm/s [9] .
MR Image Analysis
Quantitative image data analysis was performed using dedicated software (Segment version 1.9, Medviso) [17] . All functional evaluations were performed within 25 minutes per patient.
Tracing of Endocardial and Epicardial Contours
All measurements were undertaken semiautomatically. End-diastolic and end-systolic frames were identified according to the ventricular blood pool area. In all LV short-axis slices across all temporal phases (200-250 images), endocardial and epicardial contours were semiautomatically drawn and were manually corrected ( Fig. 1 ). This segmentation took 3-5 minutes. At the base of the left ventricle, the aortic outflow tract below the valve was included in volume measurements. The free papillary muscles were included for LV mass assessment and were excluded for LV volume assessment. In the basal region of the heart where the left atrium was seen, only the portion of the slice that could be identified as the left ventricle was included for measurement.
This analysis provided the time-varying course of the LV volume during the cardiac cycle. The PFR is the steepest tangent to the first part of the filling curve (Fig. 2) . Segment software automatically determines this parameter.
Analysis of the Transmitral Flow
In the flow-sensitive sequence, a round region of interest with a minimum size of 1 cm 2 was placed at the center of the mitral valve orifice on a diastolic image and propagated to other phases to obtain the transmitral curve [9] . From the analysis of the transmitral flow curve, the following measurements were performed: early phase of ventricular filling (E) and atrial phase of ventricular filling (A) mean peak velocities (in centimeters per second) and peak E velocity-to-peak A velocity (E/A) ratio.
Statistical Analysis
All continuous variables were tested for normal distribution. All normally distributed data are expressed as means ± SDs. Categoric variables are expressed as counts and percentages. Betweengroup differences of the average were compared using the unpaired Student t test for parametric data and the Mann-Whitney U test for nonparametric data. Between-group differences in numbers and percentages were compared using the chi-square test (Fisher exact test).
The distribution of CAC scores was skewed; therefore, medians and ranges are reported.
Logarithmic transformation of CAC scoresthat is, log (total CAC score + 1)-was used for parametric evaluation.
The Pearson correlation test was used for sets of normal variables. Independent associations between coronary artery calcification and LV diastolic values were studied using a linear regression with multivariable adjustments for potentially confounding factors (e.g., age, sex, history of hypertension, body mass index [BMI], duration of diabetes, LVEF, and LV mass index).
All p values of < 0.05 were considered statistically significant. All computations were performed using software (SPSS, version 20.0, SPSS).
Results
Forty-one DM2 patients and 21 age-and sex-matched normoglycemic control subjects were studied. Demographic, clinical, and imaging data of the patients and control subjects are presented in Table 1 . The mean age was 57.2 ± 7.1 years (age range, 45-72 years) and 32 (52%) patients were male.
As expected, patients with DM2 had higher BMI (p < 0.001) than control subjects. Our population of DM2 patients had a higher prevalence of systemic arterial hypertension (p = 0.001) compared with control subjects.
Left Ventricular Function
Patients with DM2 had normal conventional parameters of systolic function includ- Note-Dash (-) indicates not applicable. DM2 = type 2 diabetes mellitus, BSA = body surface area, BMI = body mass index, LV = left ventricular, EDV = end-diastolic volume, SV = stroke volume, LVEF = left ventricular ejection fraction, PFR = peak filling rate, E/A ratio = peak E velocity-to-peak A velocity ratio. a Blood pressure > 140/90 mm Hg or treatment with antihypertensive medication.
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ing LVEF and a normal LV mass index compared with control subjects.
The absolute values of PFR were significantly higher in the control subjects (Fig. 1) than in the DM2 patients (Fig. 2) (p < 0.001) .
The values of PFR indexed to end-diastolic volume (EDV) and stroke volume (SV) in DM2 patients and control subjects were similar (p = 0.616, p = 0.979, respectively).
An analysis of the transmitral parameters showed lower mitral peak E velocities (p = 0.040) and lower E/A ratios (p = 0.002) in DM2 patients compared with control subjects. Mitral peak A velocities were higher in the DM2 group, although not significantly so (p = 0.069).
To further address the relationship between hypertension and diastolic dysfunction in the patient population, we performed a subgroup analysis of the parameters of diastolic dysfunction in the DM2 group according to the presence or absence of hypertension. The results obtained are presented in Table 2 .
In this subgroup comparison, all parameters of LV diastolic function were similar in both groups.
Coronary Atherosclerosis
In the DM2 group, the average CAC score was 344 ± 754 (SD) (range, 0-4697). CAC was absent in 14 (34%) DM2 patients and was less than 10 in 18 (44%) DM2 patients. Nine of 42 (21%) DM2 patients had CAC scores greater than 10. Table 3 shows baseline and LV systolic and diastolic parameters of DM2 patients according to the presence or absence of coronary artery calcification.
Parameters of Diastolic Function and Calcium Score
DM2 patients with coronary calcification were older (p = 0.018) and had longer duration of diabetes mellitus, although not significantly so (p = 0.060). Comparing DM2 patients according to the presence or absence of coronary calcification, we found no differences in terms of sex, body surface area (BSA), BMI, or the presence of hypertension. The analysis of LV systolic function and LV mass also showed no statistically significant difference between DM2 patients with coronary calcification and those without coronary calcification.
Regarding the parameters of diastolic function, DM2 patients with coronary calcification showed lower PFR/SV (Fig. 3) (p = 0.038) and lower mitral peak E veloci- 
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ties (p = 0.024) compared with DM2 patients without coronary calcification (Fig. 4) .
Univariable and Multivariable Analyses
In the DM2 group, an increasing CAC score was negatively correlated with PFR/SV (r = -0.68, p < 0.001) (Fig. 5) .
By multivariable analysis, PFR/SV was independently associated with the presence of coronary calcification (β = -1.5, p = 0.005) after adjustment for age, sex, BMI, presence of hypertension, diabetes duration, LVEF, and LV mass index.
Discussion
In this study, CAC score and parameters of diastolic function in patients with DM2 were investigated. There were two major observations. First, differences in diastolic function were observed between DM2 patients and control subjects-in particular, in LV PFR values, mitral peak E velocities, and E/A ratios. Second, the parameters of diastolic function were different between DM2 patients with coronary calcification and those without coronary calcification-in particular, LV PFR/SV values and mitral peak E velocities.
Differences in Left Ventricular Diastolic Measures
LV filling profiles have been used to assess diastolic function by other imaging investigations, such as radionuclide cineangi- LV PFR/EDV (mL/s), mean ± SD 3.0 ± 0. With improvements in postprocessing tools, it is now possible to semiautomatically segment all phases and quickly provide the time-varying course of the LV volume during the cardiac cycle. The ventricular relaxation abnormalities can be diagnosed by a low PFR. This evaluation is based on conventional short-axis sequences without the necessity to perform a dedicated acquisition. The use of PFR values indexed to EDV and SV minimizes the dependency of PFR on EDV and heart rate. We found that the LV PFR can be easily obtained as an addition to the assessment of LV systolic function with semiautomatic contour detection and it may become a valuable asset in the evaluation of LV diastolic function. In this study, parameters of LV diastolic function were impaired in DM2 patients compared with normoglycemic control subjects. The mitral peak E velocity, E/A ratio, and LV PFR were lower in DM2 patients, indicating impaired myocardial relaxation and increased myocardial stiffness, which are the hallmarks of diastolic dysfunction [18] . DM2-related changes in LV diastolic properties are well recognized with a decrease in early diastolic filling, directly influenced by abnormal LV relaxation, mainly due to a derangement in energy supply and an increased passive stiffness due to remodeling [19] .
We acknowledge that coexisting arterial hypertension augments the impairment of LV diastolic function in diabetic patients and may partially explain the changes reported.
Interestingly, Di Bonito et al. [20] observed diastolic dysfunction in 16 normotensive patients with DM2 without microvascular complications and a short disease duration (< 1 year). Likewise, previous studies have shown that more than 40-75% of normotensive diabetic patients under excellent glycemic control had diastolic dysfunction [1, 2, 21] . In our study, the parameters of diastolic function were not different in the patients with DM2 and hypertension compared with the DM2 patients without hypertension.
Diastolic Function and Coronary Atherosclerosis
Our study of DM2 patients shows an association between diastolic function assessed by cardiac MRI and coronary artery calcification assessed by CT.
In our cohort of DM2 patients, lower PFR/SV and lower mitral peak E values were significantly associated with coronary calcification. Furthermore, the presence of coronary calcification was independently associated with PFR/SV, increasing the strength of this association. Our results are consistent with the findings of other studies. Colletti et al. [13] studied 386 subjects, including 39 patients with diabetes mellitus, and also found a relation of a CAC score of greater than 100 with decreased MRI-derived parameters of LV diastolic filling. Scholte et al. [22] reported similar conclusions using echocardiography-derived indexes of diastolic function (transmitral and pulmonary vein flow recording) and systolic function (global longitudinal strain). Their results point to an association of coronary atherosclerosis with subclinical LV dysfunction evaluated in DM2 patients [22] .
Mechanisms underlying the relationship of subclinical atherosclerosis and diastolic function are probably related to vascular function.
Poulsen et al. [23] suggested that abnormal LV filling in DM2 patients is closely associated with abnormal myocardial perfusion on myocardial perfusion scintigraphy. Macrovascular coronary artery disease could also contribute to this subclinical myocardial damage [22] . In coronary macrovasculature, formation of atheroma may lead to luminal obliteration, recurrent thrombosis, distal embolization, and clinically silent microinfarctions [11] .
The findings of this study contribute to the available knowledge, favoring the hypothesis that there is a link between subclinical LV diastolic dysfunction and asymptomatic atherosclerosis.
In our study, the DM2 patients with coronary artery calcification had greater LV mass than the DM2 patients without coronary calcification, but the difference did not quite achieve acceptable levels of statistical significance (p = 0.055). LV mass represents an endpoint of cumulative LV insult, and although not a diagnostic criteria for LV diastolic dysfunction, increased LV mass is associated with diastolic dysfunction ranging from abnormal relaxation to coexistent restrictive physiology due to increased myocardial stiffness [24] . Systemic arterial hypertension and diabetes mellitus are known causes of LV hypertrophy. Notwithstanding the high prevalence of arterial hypertension in our population, none of our subjects had an LV mass above the normal range (LV mass indexed to BSA > 86 g/m 2 for men and > 72 g/m 2 for women) [25, 26] .
The originality of our study is the use of cardiac MRI-derived parameters of diastolic function and the relatively high number of DM2 patients with a low CAC score. We had a relatively large percentage of DM2 patients 
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with a CAC score equal to zero, something that we were not expecting in a population of DM2 patients between the ages of 45 and 72 years. A basic limitation of this study must be acknowledged. This study was a cross-sectional study with a relatively small number of subjects; therefore, studies using larger patient cohorts are needed to clarify the association between LV diastolic function and coronary atherosclerosis.
Our findings are limited by an inability to eliminate causal relationships with important clinical factors, such as medications used, serum concentrations of glucose and glycosylated hemoglobin (HbA1c), dyslipidemia, retinopathy, microalbuminuria, and smoking status. Also, the high prevalence of hypertension in our population makes it difficult to interpret the findings and clarify the responsibility of diabetes in the results obtained.
The possibility of influence of myocardial ischemia on LV diastolic function cannot be completely excluded. The evaluation of coronary stenosis and plaque characterization were not performed in our study because CT angiography is not recommended in asymptomatic DM2 patients. Because myocardial perfusion, endothelial function, coronary flow reserve, and arterial stiffness were not evaluated in the current study, a more comprehensive understanding of the pathophysiologic process should be the focus of future research.
We consider the analysis of cine and transmitral flow images to be sufficient to exclude left-sided valvular disease as a potential pitfall of abnormal transmitral flow. Regarding the exclusion of infiltrative myocardial disease, we neither studied myocardial delayed enhancement nor performed endomyocardial biopsy. Nevertheless, none of our subjects had increased LV myocardial end-diastolic thickness, pericardial thickening, pericardial effusion, or pleural effusion.
Recent findings [27] have shown an improvement in transmitral flow assessment by applying 3D three-directional velocity-encoding instead of the conventional approach of 2D one-directional through-plane velocity-encoded MRI with a fixed acquisition plane used in our study.
Normalizing early mitral velocity (E) for the influence of myocardial relaxation by combining E with early diastolic mitral septal tissue velocity (Ea) may be performed by MR tissue phase-contrast imaging, and this is an important parameter of diastolic function that has been established [28] . On the other hand, there are still conflicting data regarding the relation of E/Ea ratio and LV filling pressure [29, 30] .
The evaluation of coronary stenosis and characterization of plaque were not performed in our study because CT angiography is not recommended in asymptomatic DM2 patients.
This study highlights certain key points for the routine use of cardiac MRI to study diastolic function in diabetic patients and the relation of diastolic function with coronary atherosclerosis. First, cardiac MRI shows a decrease in diastolic function in DM2 and may allow the diagnosis of subclinical diastolic dysfunction in this high-risk population. Second, diastolic dysfunction is possibly related to the presence of coronary atherosclerosis. 
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